Interstitial lung disease associated with immune-checkpoint inhibitors in malignant diseases

被引:0
作者
Yamagata, A. [1 ]
Yokoyama, T. [1 ]
Fukuda, Y. [1 ]
Ishida, T. [1 ]
机构
[1] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1307P
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Future directions in immune-checkpoint inhibitors in NSCLC
    Hayashi, Hidetoshi
    CANCER SCIENCE, 2018, 109 : 1225 - 1225
  • [22] A CASE OF IMMUNE-CHECKPOINT INHIBITOR MYOCARDITIS AND INTERSTITIAL NEPHRITIS
    Godding, Mark J.
    Russell, Raymond R., III
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3598 - 3598
  • [23] Tumour burden and efficacy of immune-checkpoint inhibitors
    Dall'Olio, Filippo G.
    Marabelle, Aurelien
    Caramella, Caroline
    Garcia, Camilo
    Aldea, Mihaela
    Chaput, Nathalie
    Robert, Caroline
    Besse, Benjamin
    NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (02) : 75 - 90
  • [24] Immune-checkpoint inhibitors march on, now in combinations
    Cormac Sheridan
    Nature Biotechnology, 2014, 32 : 297 - 298
  • [25] Palmoplantar Pustulosis Caused by Immune-Checkpoint Inhibitors
    Furuta, Hiromi
    Kato, Seiichi
    Masago, Katsuhiro
    Hida, Toyoaki
    CLINICAL LUNG CANCER, 2021, 22 (06) : E829 - E832
  • [26] Synergistic Strategies for Lung Cancer Immunotherapy: Combining Phytochemicals and Immune-Checkpoint Inhibitors
    Gao, Quan
    Wu, Hao
    Li, Zhengjun
    Yang, Zijing
    Li, Lin
    Sun, Xueni
    Wu, Qibiao
    Sui, Xinbing
    PHYTOTHERAPY RESEARCH, 2025,
  • [27] Immune-checkpoint inhibitors and neurological adverse events
    Tummala, Sudhakar
    LANCET NEUROLOGY, 2023, 22 (12) : 1093 - 1094
  • [28] Immune-checkpoint inhibitors march on, now in combinations
    Sheridan, Cormac
    NATURE BIOTECHNOLOGY, 2014, 32 (04) : 297 - 299
  • [29] Pulmonary Complications Secondary to Immune-Checkpoint Inhibitors
    Albitar, H. A.
    Leventakos, K.
    Duma, N.
    De Moraes, A. Gallo
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [30] Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma
    Hotta, Katsuyuki
    Fujimoto, Nobukazu
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)